Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Yarning places
    Yarning places
  • Programs
    Programs
  • Organisations
    Organisations
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Jobs
    Jobs
Australian Indigenous HealthBulletin
 

National guidelines for medication-assisted treatment of opioid dependence (2014)

Author

Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N

City

Canberra

Type

Report

Institution

National Drug Strategy

 

Description

This document is intended to provide a broad policy context and a framework for medication-assisted treatment of opioid dependence.

It provides clinical guidelines on approaches involving the use of methadone, buprenorphine or naltrexone for the treatment of opioid dependence. It aims to provide guidance in the selection and management of patients seeking pharmacotherapies for opioid dependence, and to support the provision to patients of accurate information about methadone, buprenorphine and naltrexone.

Information includes:

This document updates and replaces four previously separate documents:

Abstract adapted from National Drug Strategy

When to use this resource

These guidelines are primarily intended for generalist settings, such as general practice and hospital, clinic or community settings. Specialised alcohol and other drug treatment services may also find them helpful.

Contact details

National Drug Strategy Team
Email: nationaldrugstrategy@health.gov.au

Links

 
Last updated: 15 July 2014
 
Return to top